CN Patent

CN113950328A — 用于治疗亨廷顿病及其症状的包含普利多匹定及其类似物的组合物

Assigned to Prenia Neurotherapy Co ltd · Expires 2022-01-18 · 4y expired

What this patent protects

本发明涉及一种治疗患有亨廷顿病和/或其症状的人类患者的方法，该方法包括向患者施用包含普利多匹定或其药学上可接受的盐及其类似物或其药学上可接受的盐的药物组合物。

USPTO Abstract

本发明涉及一种治疗患有亨廷顿病和/或其症状的人类患者的方法，该方法包括向患者施用包含普利多匹定或其药学上可接受的盐及其类似物或其药学上可接受的盐的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN113950328A
Jurisdiction
CN
Classification
—
Expires
2022-01-18
Drug substance claim
No
Drug product claim
No
Assignee
Prenia Neurotherapy Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.